Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protective effect or symptomatic effect of deprenyl?

O S Kofman

    The New England Journal of Medicine
    |June 10, 1993
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Complications of therapy in Parkinson's disease.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Deprenyl: protective vs. symptomatic effect.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·1991
    Same author

    Bromocriptine in the management of end of dose deterioration in Parkinson's disease.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·1984
    Same author

    Are levodopa "drug holidays" justified?

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·1984
    Same author

    Bromocriptine (ParlodelR) in the treatment of Parkinson's disease.

    Progress in neuro-psychopharmacology & biological psychiatry·1982
    Same author

    A therapeutic paradox? Combined treatment of Parkinson's disease with levodopa and methyldopa.

    Archives of neurology·1973